Cargando…
CGM in the Hospital: Is It Ready for Prime Time?
PURPOSE OF REVIEW: The use of continuous glucose monitoring (CGM) in the hospital setting is growing with more patients using these devices at home and when admitted to the hospital, especially during the COVID-19 pandemic. RECENT FINDINGS: Historically, most evidence for CGM use in the inpatient se...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261155/ https://www.ncbi.nlm.nih.gov/pubmed/35796882 http://dx.doi.org/10.1007/s11892-022-01484-x |
_version_ | 1784742210251522048 |
---|---|
author | Buschur, Elizabeth O. Faulds, Eileen Dungan, Kathleen |
author_facet | Buschur, Elizabeth O. Faulds, Eileen Dungan, Kathleen |
author_sort | Buschur, Elizabeth O. |
collection | PubMed |
description | PURPOSE OF REVIEW: The use of continuous glucose monitoring (CGM) in the hospital setting is growing with more patients using these devices at home and when admitted to the hospital, especially during the COVID-19 pandemic. RECENT FINDINGS: Historically, most evidence for CGM use in the inpatient setting was limited to small studies utilizing outdated CGM technology and analyzing accuracy of sensor measurements. Previous studies have shown reduced sensor accuracy during extreme hypo- or hyperglycemia, rapid fluctuations of glucose, compression of the sensor itself, and in those who are critically ill. Studies that are more recent have shown CGM to have adequate accuracy and may be effective in reducing hypoglycemia in hospitalized patients; some studies have also showed improvement in time in target glycemic range. Furthermore, CGM may reduce nursing workload, cost of inpatient care, and use of personal protective equipment and face-to-face patient care especially for patients during the COVID-19 pandemic. SUMMARY: This review will describe the evidence for use of CGM in hospitalized critically ill or non-critically ill patients, address accuracy and safety considerations, and outline paths for future implementation. |
format | Online Article Text |
id | pubmed-9261155 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-92611552022-07-07 CGM in the Hospital: Is It Ready for Prime Time? Buschur, Elizabeth O. Faulds, Eileen Dungan, Kathleen Curr Diab Rep Hospital Management of Diabetes (A Wallia and JJ Seley, Section Editors) PURPOSE OF REVIEW: The use of continuous glucose monitoring (CGM) in the hospital setting is growing with more patients using these devices at home and when admitted to the hospital, especially during the COVID-19 pandemic. RECENT FINDINGS: Historically, most evidence for CGM use in the inpatient setting was limited to small studies utilizing outdated CGM technology and analyzing accuracy of sensor measurements. Previous studies have shown reduced sensor accuracy during extreme hypo- or hyperglycemia, rapid fluctuations of glucose, compression of the sensor itself, and in those who are critically ill. Studies that are more recent have shown CGM to have adequate accuracy and may be effective in reducing hypoglycemia in hospitalized patients; some studies have also showed improvement in time in target glycemic range. Furthermore, CGM may reduce nursing workload, cost of inpatient care, and use of personal protective equipment and face-to-face patient care especially for patients during the COVID-19 pandemic. SUMMARY: This review will describe the evidence for use of CGM in hospitalized critically ill or non-critically ill patients, address accuracy and safety considerations, and outline paths for future implementation. Springer US 2022-07-07 2022 /pmc/articles/PMC9261155/ /pubmed/35796882 http://dx.doi.org/10.1007/s11892-022-01484-x Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Hospital Management of Diabetes (A Wallia and JJ Seley, Section Editors) Buschur, Elizabeth O. Faulds, Eileen Dungan, Kathleen CGM in the Hospital: Is It Ready for Prime Time? |
title | CGM in the Hospital: Is It Ready for Prime Time? |
title_full | CGM in the Hospital: Is It Ready for Prime Time? |
title_fullStr | CGM in the Hospital: Is It Ready for Prime Time? |
title_full_unstemmed | CGM in the Hospital: Is It Ready for Prime Time? |
title_short | CGM in the Hospital: Is It Ready for Prime Time? |
title_sort | cgm in the hospital: is it ready for prime time? |
topic | Hospital Management of Diabetes (A Wallia and JJ Seley, Section Editors) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261155/ https://www.ncbi.nlm.nih.gov/pubmed/35796882 http://dx.doi.org/10.1007/s11892-022-01484-x |
work_keys_str_mv | AT buschurelizabetho cgminthehospitalisitreadyforprimetime AT fauldseileen cgminthehospitalisitreadyforprimetime AT dungankathleen cgminthehospitalisitreadyforprimetime |